Survival after acute lung injury (ALI) depends on prompt alveolar repair, a process frequently subverted by the development of granulation tissue within the alveolar airspace. Immunohistochemical examination of the intraalveolar granulation tissue confirmed that capillaries as well as myofibroblasts were the principal cellular constituents. We therefore hypothesized that angiogenesis factors would be present on the air-lung interface after ALI. To evaluate this hypothesis, bronchoalveolar lavage fluid from patients with ALI (a = 25) and patient controls (a = 8) was examined for angiogenesis bioactivity by its ability of induce endothelial cell migration. While lavage fluid from controls had no bioactivity, lavage fluid from 72% of patients with ALI promoted endothelial cell migration. Heparin affinity, ion exchange, and gel filtration chromatography resolved the bioactivity into at least two moieties. One appeared identical to the well characterized endothelial cell growth factor, basic fibroblast growth factor. The other was a 150-kD non-heparin binding protein that mediated endothelial cell migration and attachment in vitro, and the growth of new vessels in vivo. These data are consistent with the hypothesis that the growth of capillaries into the alveolar airspace results from angiogenesis factors present on the alveolar surface of the lung after ALI. (J. Clin. Invest. 1991. 88:1386-1395
Introduction
Acute lung injury is an abrupt alteration of the pulmonary parenchyma leading to functional impairment of the gas exchange apparatus. This disorder occurs after direct pulmonary injury such as aspiration of gastric contents, or after sepsis or trauma occurring in another part of the body. Despite significant advances in critical care technology, in its most fulminant form, the adult respiratory distress syndrome (ARDS),' acute lung injury exacts a mortality in excess of 50%. ARDS constitutes a major public health problem with an estimated 150,000 patients treated annually in the United States (1) .
Anatomically, acute lung injury is an explosive transmural process. There is widespread death of the alveolar epithelium and microcirculatory endothelium as well as significant interstitial edema (2, 3) . When alveolar repair is to be effective, a precisely coordinated sequence of cellular migration and replication reconstitutes the air-lung interface, interstitium, and blood-lung interface. The repair process, however, frequently fails. Under these circumstances, an acute fibroproliferative response ensues in which granulation tissue rapidly fills the alveolar airspace, precluding effective gas exchange (4) .
While most attention has been focused on the role of the interstitial myofibroblast in the evolution of acute intra-alveolar granulation, new blood vessel growth is a prominent component of the fibroproliferative response (5) . The development of new blood vessels is controlled by a discrete set of peptides, collectively referred to as angiogenesis factors (6, 7) . For new blood vessels to grow into the alveolar airspace, microvascular endothelial cells must migrate through the injured alveolar wall and attach to the intra-alveolar provisional matrix. We therefore designed this study to examine the hypothesis that angiogenesis factors capable of stimulating endothelial cell migration and attachment would be present on the air-lung interface after acute lung injury. The data indicate that angiogenesis bioactivity was present in the lungs ofmost patients after acute lung injury. Two peptides accounted for the majority of the bioactivity. One had a molecular mass of 18 kD and appeared identical to the established endothelial cell growth factor, basic fibroblast growth factor (bFGF). The other was a 1 50-kD molecule that stimulated directed migration and attachment of endothelial cells in vitro, angiogenesis in vivo, and appeared to be distinct from previously characterized angiogenesis factors.
Methods

Study population
Two groups ofpatients underwent bronchoscopy with bronchoalveolar lavage for the purpose of examining the air-lung interface for the presence of angiogenesis factors. 1 . Acute lung injury (n = 25). Patients with severe acute lung injury being supported with mechanical ventilation who met the standard clinical criteria for ARDS were included in this cohort (8, 9) . All 17) were studied early in their clinical course (day 2-4) as soon as bron-choalveolar lavage could be safely performed. The remainder of the patients (n = 8) were studied later in their clinical course (day 10-21) in order to provide samples which temporally corresponded to the postmortem whole lung lavage samples obtained for preparative biochemical examination. 2. Patient controls (n = 8). This group consisted of normal individuals and patients undergoing bronchoscopy for evaluation of a localized process. Bronchoalveolar lavage was performed in an area distant from the lesion.
Immunohistochemistry
Representative lung tissue was obtained at autopsy from patients who died of acute lung injury (n = 12), as well as 10 control cases with no pulmonary abnormalities. The tissue was fixed in 10% neutral-buffered formalin for 6 to 18 h and embedded in paraffin. 5-M sections of all specimens were cut and mounted on glass slides that had been coated with a chrome-alum mixture.
Deparaffinization was accomplished with Americlear (American Scientific Products, Inc., McGaw Park, IL) and absolute alcohol, and endogenous peroxidase was blocked by incubation in methanol-0.6% hydrogen peroxide for 30 min. The sections were rehydrated in graded alcohols, distilled water, and PBS (pH 7.4).
Primary antibodies to factor VIII-related antigen and vimentin were applied for 18 h at 4VC in moisture chambers. Localization of antibody binding was visualized with the avidin-biotin-peroxidase complex (ABC) procedure, as described previously (10), using 3,3'-diaminobenzidine hydrochloride (0.25 mg/ml with 0.003% hydrogen peroxide) as the chromogen. Sections were then immersed briefly in 0.125% osmium tetroxide (wt/vol), counterstained with Harris hematoxylin, and coverslipped with a synthetic mounting medium.
Positive controls consisted of unrelated tissue-banked specimens known to contain the determinants ofinterest; "internal controls" such as bronchial epithelium and large pulmonary blood vessels were also assessed to verify methodologic integrity. Sections of all study cases were also labeled with ABC after substitution of nonimmune mouse ascites fluid for primary antibodies; these served as negative controls. All immunohistochemical preparations were reviewed and interpreted by one observer.
Bronchoalveolar lavage
Bronchoalveolar lavage was performed in order to obtain fluid from the air-lung interface as previously described (1 1). In acute lung injury patients receiving mechanical ventilation, bronchoscopy was performed through an endotracheal tube using an appropriate adapter. All patients received 100% oxygen during the procedure, and oxygen saturation and electrocardiogram were continuously monitored. The procedure was terminated ifthe oxygen saturation fell below 90% for more than 1 min. Up to three separate anatomic sites were sampled in each patient with acute lung injury. In patient controls, after local anesthesia of the upper airway, the bronchoscope was wedged in a peripheral bronchus and five, 20 ml aliquots of 0.9% saline were instilled and removed by gentle suction. Up to three separate anatomic locations were sampled in each patient. In a subset of acute lung injury patients who died from respiratory insufficiency, whole lung lavage was performed within 2 h of death ex vivo. Whole lung lavage was performed by cannulating the mainstem bronchus with plastic tubing followed by the instillation of sterile PBS (30 cm H20 pressure). Fluid was recovered by gravity flow.
Processing ofbronchoalveolar lavage specimens Recovered bronchoalveolar lavage effluent was separated from cells by centrifugation (600 g X 15 min). The cell free lavage effluent was either aliquoted and stored at -70°C before assay, or kept at 4°C ifthe assay was to be performed immediately. Protein concentration of cell free lavage effluent was determined using a colorimetric assay (Pierce Chemical Co., Rockford, IL), and albumin concentration was quantified by ELISA as previously described (12) .
Biological assay oflavagefluid
The bioassays used were chosen to assess two of the cellular responses integral to the process of angiogenesis: (a) endothelial cell migration, and (b) the formation of capillary networks in vivo (6, 7) . To identify the presence of angiogenesis bioactivity, lavage effluent from all patients was analyzed using an endothelial cell migration assay. Confirmation of angiogenesis bioactivity detected in the migration assay was performed using an in vivo angiogenesis assay.
MIGRATION ASSAY
Endothelial cell migration was assessed in a modified Boyden chemotaxis chamber (Nucleopore, Pleasanton, CA), as previously described (13, 14) . To ensure the generalizability of the bioassay results, both microvascular and large vessel endothelial cells were used in the chemotaxis assay. Rabbit wound microvascular endothelial cells were isolated from sponges implanted in the backs of New Zealand white rabbits by modifying the isolation procedure used to harvest rabbit brain capillary endothelial cells, as described (14) . Bovine Biochemical characterization of the angiogenesis bioactivity consisted of sequential chromatography using heparin affinity, ion exchange, and gel filtration. The starting material for these studies was 1 liter of lavage fluid obtained from whole lung lavage of postmortem lungs (processed in . 2 h). All procedures were carried out using this material and confirmed in other routinely obtained lavage fluid as quantities permitted.
One class of endothelial cell growth factors, the fibroblast growth factors, avidly binds heparin (18) (19) (20) . To isolate members ofthis class, bronchoalveolar lavage fluid was applied to a heparin-sepharose column in equilibration buffer (0.05 M NaCl, 0.01 M Tris, pH 7.4). The column was developed stepwise with buffers of increasing ionic strength (0.5 M NaCl, 1 M NaCl, 1.5 M NaCl, 2 M NaCl). Fractions were dialyzed against PBS before the assay. Bioactivity binding to heparin-sepharose was further analyzed by SDS-PAGE and Western blot analysis (see below).
Bioactive fractions of lavage fluid failing to bind to heparin-sepharose were directly applied in equilibration buffer (0.125 M NaCl, 0.01 M Tris, pH 7.4) to an anion exchange resin (diethylamino ethyl sepharose;
[DEA-S]). The column was developed in a stepwise fashion with buffered NaCl solutions (0.01 M Tris, pH 7.4) of increasing ionic strength: 0.25 M NaCl, 0.50 M NaCl, 0.75 M NaCl, 1.0 M NaCl. Fractions were dialyzed against PBS before the assay.
The DEAE-S fractions with biological activity were further purified using a strong anion exchange resin (Mono Q column; Pharmacia, Inc. Piscataway, NJ) and a linear gradient as dictated by the results of the stepwise elution. Active fractions were dialyzed and applied in starting buffer (0.125 M NaCI, 0.01 M Tris, pH 7.4). The column was developed with a linear salt gradient (0.125-0.300 M NaCl). Fractions were directly examined for biological activity without further handling.
To obtain an estimate of molecular mass, the Mono Q fractions with biological activity were applied to a gel filtration column (Superose 12, 10 X 300 mm, flow rate = 0.5 ml/min; Pharmacia). The column was developed with PBS, pH 7.4, containing 10% acetonitrile, to minimize nonspecific interaction with the gel filtration matrix. Pilot studies indicated that 10% acetonitrile had no effect on the bioactivity in the chemotaxis assay. Molecular weight standards included: human IgG (166 kD), human serum albumin (66 kD), ovalbumin (44 kD), soybean trypsin inhibitor (21 kD), and aprotinin (6.5 kD). Fractions were directly examined for biological activity. Ofnote, instability ofthe bioactivity in higher concentrations of organic buffer (> 30% acetonitrile) precluded further purification by reverse phase chromatography.
ADHESION ASSAY
Directed endothelial cell migration can occur as a result of movement ofendothelial cells toward a positive chemical gradient (chemotaxis) or as a result ofcontact with proteins that promote cellular adhesion (haptotaxis) (14, 21, 22) . To determine ifthe angiogenesis bioactivity identified by the chemotaxis assay promoted cellular attachment, adhesion of endothelial cells to substratum-bound proteins was determined using a standard adhesion assay as described (23) . Test Immunohistochemically, in ARDS specimens, small capillary-sized blood vessels labeled by anti-factor VIII-related antigen ( Fig. 1) lung injury (n = 9), and none of the samples from patient controls (n = 4), stimulated microvascular endothelial cell migration (P < 0.01; Fig. 2 B) . Checkerboard analysis revealed that endothelial cell migration induced by lavage fluid was due both to directed cell migration as well as random migration (Fig. 3 ). demonstrated bioactivity at any ofthe tested dilutions. In addition, the presence of inhibitors of endothelial cell migration in patient control samples was formally excluded when quantitative recovery ofbioactivity was observed using two approaches: (a) addition of the positive control (platelet lysate) in parallel assays, and (b) equal mix experiments with selected acute lung injury patient samples (data not shown). Likewise, in selected acute lung injury samples in which endothelial cell migration was not observed, the lavage fluid was studied using an equal mix experiment in which the positive control was added to the lavage sample. Using this approach, significant inhibition was not observed.
In vivo neovascularization. Confirmation ofthe angiogenesis bioactivity detected in the migration assay was obtained by the ability of selected bioactive samples to induce corneal neovascularization. When concentrated lavage fluid from the patients demonstrating the greatest amount ofin vitro chemotactic bioactivity (n = 2) was implanted in the avascular cornea of rabbits, both samples induced capillary growth. Histologically, inflammation characterized by accumulation of macrophages into the inflammatory site was associated with the new microvessels, leaving open the possibility that the lavage fluid did not induce angiogenesis directly, but rather by inducing an inflammatory response. Significantly, no growth of new vessels was induced by lavage fluid from patient controls (n = 2).
Biophysical properties ofthe angiogenesis bioactivity. Biophysical characterization of the angiogenesis bioactivity revealed properties expected of a peptide(s). The bioactivity was destroyed by boiling (1000C, 15 min), acidic conditions (pH 3), and protease exposure (trypsin 0.2 mg/ml, 30 min, 370C). Soybean trypsin inhibitor was used to neutralize trypsin activity. When soybean trypsin inhibitor was mixed equally with the positive control, platelet releasate, chemotactic activity was preserved. In addition, the bioactivity was not extracted into nonpolar solvents (Table I) . These results served as the starting point for further purification and characterization. Biochemical characterization ofthe angiogenesis bioactivity. A characteristic of several extracellular matrix proteins (e.g., fibronectin, laminin, and thrombospondin) that promote cell migration and adhesion and a class ofendothelial cell peptide growth factors (fibroblast growth factor family) is their ability to bind to heparin. When bronchoalveolar lavage effluent was applied to heparin-sepharose, 30% ofthe angiogenesis bioactivity bound at low ionic strength and remained bound up to 1.5 M NaCl, as determined in the large vessel endothelial cell migration assay. The bound bioactivity eluted from heparin at 2 M NaCl.
Among the characterized heparin binding endothelial cell growth factors, only bFGF binds avidly at 1.5 M NaCl. Therefore, the heparin binding bioactivity eluting at 2 M NaCl was subjected to Western blot analysis using an anti-bFGF primary antibody. An 1 8-kD band comigrating with a bFGF standard (recombinant bFGF) was identified (Fig. 4) . In addition, a lower molecular weight (-12 to 13 kD) bFGF immunoreactive band was present. No bFGF immunoreactivity was demonstrated in the heparin-sepharose unbound fraction, nor in any of the fractions eluting at lower ionic strengths (data not shown).
The majority (70%) ofthe angiogenesis bioactivity failed to bind heparin, and was evaluated for its ability to bind to ion-exchange resins. 50% of the bioactivity bound to the weak anion Chromatographic analysis of the bioactivity using a strong anion exchanger (Mono Q column; Pharmacia) and a linear salt gradient revealed a single peak of bioactivity eluting from the column at -260 mM NaCQ (Fig. 5) . Gel filtration chromatography of the Mono Q peak was carried out to further purify the bioactivity and to obtain an estimate ofits molecular weight. The endothelial cell migration bioactivity eluted just after the human IgG standard, corresponding to an approximate molecular weight of 150 kD (Fig. 6) .
The biochemical characteristics (heparin affinity, ion exchange properties) of the angiogenesis bioactivity were examined in relation to the timepoint in the clinical course that a patient was studied. The biochemical properties of the angiogenesis bioactivity present in bronchoalveolar lavage fluid obtained from acute lung injury patients early in their clinical course (days 2-4) were identical to those present in the lavage fluid obtained from patients later in their clinical course (days 10-21).
Biologicalproperties ofthe 150-kD bioactivity. The molecular weight estimate of 150 kD indicated that the angiogenesis bioactivity was larger than the majority ofcellular-derived peptide growth factors. However, it fell within the range of a variety of extracellular matrix protein and degradation products that promote both endothelial cell migration and adhesion. Therefore, the 1 50-kD bioactivity was evaluated for its ability to promote endothelial cell attachment. When a plastic substratum was coated with increasing concentrations of the 150-kD peptide, there was a dose-dependent increase in endothelial cell adhesion (Fig. 7) . Type IV collagen and fibronectin, two extracellular matrix proteins that promote endothelial cell adhesion in a dose-dependent fashion, were used as positive controls. Bovine serum albumin,.which does not promote endothelial cell attachment, was used as a negative control. In mediating endothelial cell attachment the 1 50-kD peptide was at least as potent as type IV collagen and one to two logs more potent than intact fibronectin.
Based on these results, it became apparent that the endothelial cell migration observed in response to crude lavage fluid might have been dependent on the fibronectin used to coat the polycarbonate filters. Therefore, the migration assay was repeated using the 1 Coating Concentration (jig/ml) To plausibly be involved in neovascularization of the airspace after acute lung injury, the 150-kD bioactivity should promote new capillary growth in vivo. When , 10 ng of the 150-kD bioactivity was incorporated into Hydron and implanted in the avascular cornea ofrabbits, new capillary growth was observed. Vessels were observed to be growing from the limbus to the Hydron pellet containing the 1 50-kD angiogenesis bioactivity implanted within the corneal stroma. Notably, histological examination ofthe corneas on day 2 and 7 did not show the presence of an inflammatory infiltrate. Thus, partial purification ofthe angiogenesis bioactivity present in the crude lavage fluid removed proinflammatory molecules but preserved the angiogenesis activity. (Fig. 8, A and B) .
Discussion
Replacement ofthe alveolar airspace with granulation tissue is the central morphologic feature characterizing the lungs of patients dying after acute lung injury (4). Angiogenesis, a process consisting of endothelial cell migration and replication in response to a specific set of exogenous signals, is an integral feature of this granulation tissue formation. This study demonstrates the presence of growth regulatory signals recovered from the air-lung interface that have the ability to modulate endothelial cell function. Analysis of the angiogenesis bioactivity reveals the presence oftwo discrete moieties: (a) an 1 8-kD heparin binding factor that appears to be identical to bFGF; and (b) a 1 50-kD factor that promotes endothelial cell migration and adhesion in a dose-dependent fashion in vitro, and induces the formation of microvessels in vivo.
Wound repair: a paradigm for studying the granulation tissue response The primary tissue healing response to wounding is the formation of granulation tissue followed by epithelialization (29) .
When it occurs after a surface wound, the formation ofgranulation tissue is an adaptive response, bringing about closure of the wounded integument. However, when this highly conserved response to tissue injury occurs after disruption of the alveolar wall, the alveolar airspace fills with granulation tissue, obliterating the gas exchange apparatus. In this anatomic location, granulation tissue represents a maladaptive response to tissue injury, preventing effective gas exchange. Despite its adverse effect on lung function, the anatomic similarity of intraalveolar granulation to normal wound healing suggests that the extensive body of experimental information pertaining to wound healing may provide insight into the processes leading to intra-alveolar fibrosis following lung injury.
In the lung as in the skin, granulation tissue develops in a dynamic inflammatory milieu. Anatomically, the injured space is rapidly filled with the contents of degranulating platelets as well as plasma proteins (30, 31 The process ofangiogenesis, which is highly coordinated, is likely to be under the control of multiple molecular signals (36) . New vessel formation involves the migration of endothelial cells toward a chemotactic stimulus. The migrating endothelial cells may then become aligned with one another and undergo replication to form a solid sprout (36) (37) (38) (39) . Based on this information and the results of this study it is useful to consider these signals in two groups: first, signals that function as classical peptide growth factors (e.g., bFGF), and second, signals that may function in solid phase as mediators ofchemotaxis and adhesion (e.g., the 150-kD peptide).
Peptide growth factors capable of stimulating endothelial cell growth, migration and/or angiogenesis. A defined set of peptide growth factors are capable of stimulating endothelial cell growth or migration and/or angiogenesis. In general they derive from both recruited inflammatory cells as well as parenchymal. cells and include platelet-derived endothelial cell growth factor (40) (41) (42) , and macrophage-derived transforming growth factor alpha (TGFa) (43, 44) . The relative importance of these two angiogenesis factors to the new vessel growth observed after acute lung injury remains uncertain.
One of the two moieties identified at the alveolar surface in this study, bFGF, has been reported to stimulate the replication of endothelial cells in vitro and new microvessel growth in vivo (45, 46) . However, recent investigation has failed to show significant chemoattractant or in vivo angiogenic activity using recombinant bFGF (47) . The results ofour investigation indicate that lavage fluid eluted from heparin-sepharose with 2 M NaCl promotes large vessel endothelial cell migration and contains bFGF as identified by Western analysis. However, because bFGF was not purified, its role in endothelial cell migration remains inferential. Data linking bFGF with the process of wound healing include its ability to cause rapid neovascularization in the cornea and skin, as well as fibroplasia in the dermis after wounding (45, (48) (49) (50) . These observations support the notion that bFGF is involved in neovascularization and wound repair.
The origin ofbiologically active bFGF in wounded tissue is incompletely understood. According to one hypothesis, bFGF produced by endothelial cells is released and sequestered in the basement membrane bound to heparan sulfate (and possibly other glycosaminoglycans) (51) (52) (53) (54) . In the inflammatory environment ofwounded tissue, bFGF stored within the basement membrane is released enzymatically (e.g., plasmin or heparinase) where it can act on target microvascular cells to promote angiogenesis (53) . While the origin ofthe bFGF recovered from the alveolar epithelial surface after acute lung injury remains to be determined, this study provides clear evidence that this known endothelial cell growth factor is present at a site where new blood vessels are forming.
Moieties mediating endothelial cell migration and adhesion. A significant portion ofthe identified angiogenesis bioactivity recovered from the lungs of patients after acute lung injury is a 1 50- migration factor and adhesogen. In addition, it promotes in vivo angiogenesis without causing inflammation. Its biochemical and biological properties suggest that it belongs to the family of extracellular matrix elements that promote endothelial cell attachment and migration. Several studies support the concept that components ofthe extracellular matrix and basement membrane are important modulators of those endothelial cell functions necessary for wound healing and new vessel growth and include Type IV collagen, thrombospondin, fibronectin, and/or fragments of fibronectin (22, (55) (56) (57) (58) (59) (60) (61) (62) (63) .
Granulation ofthe alveolar airspace after acute lung injury: an hypothesis
Morphological studies of lung tissue after acute lung injury have documented the development and progression ofgranulation tissue as it obliterates the alveolar airspace. The anatomic similarity of this process to wound healing is striking. Disruption of the endothelial and epithelial cell layers and their basement membranes results in direct communication between the microvascular bed, interstitium, and alveolar airspace. As a consequence of this disruption, an intra-alveolar exudate rich in plasma proteins and cells, including platelets and macrophages, accumulates in the alveolar airspace (64) . As the process evolves, the intra-alveolar exudate becomes organized by the migration of mesenchymal cells and endothelial cells from the interstitium through rents in the disrupted epithelial barrier into the airspace, resulting in the formation of granulation tissue within the airspace. Based on the wound healing paradigm, both cellular and matrix derived protein products are capable of providing signals for neovascularization of the alveolar airspace after acute lung injury. One of these signals identified in this study is the endothelial cell growth factor bFGF. Possible cellular sources for bFGF include the alveolar macrophage and microvascular endothelial cells. In addition, it is possible that bFGF bound to basement membranes is released by molecules generated by the explosive inflammatory response associated with early phases ofacute lung injury. A large portion ofthe angiogenesis bioactivity within the alveolar airspace after acute lung injury is an -1 50-kD peptide. Although the precise chemical structure of the 150-kD molecule angiogenesis factor remains to be established, its ability to promote cell attachment in addition to migration and angiogenesis in vivo, suggests that it belongs to the family of adhesogenic extracellular matrix elements. Candidate molecules include fragments of collagen (type IV) or fibronectin. Alternatively, it may be related to the cell-derived protein thrombospondin. Collectively these molecules share with the 1 50-kD angiogenesis factor the ability to promote endothelial cell adhesion. Purification to homogeneity will be required for a definitive answer to its identity. Independent ofthe precise identity of this biologically-active moiety, this investigation supports the conclusion that neovascularization of the airspace, stimulated by at least two distinct peptide moieties, may be one ofthe central processes in the pathogenesis ofintraalveolar granulation after acute lung injury.
